AstraZeneca
AZN
#48
Rank
โ‚ฌ251.03 B
Marketcap
80,97ย โ‚ฌ
Share price
-2.47%
Change (1 day)
30.39%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: โ‚ฌ251.03 Billion

As of January 2026 AstraZeneca has a market cap of โ‚ฌ251.03 Billion. This makes AstraZeneca the world's 48th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ251.03 B2.38%
2025โ‚ฌ245.19 B24.2%
2024โ‚ฌ197.42 B4.54%
2023โ‚ฌ188.85 B-3.71%
2022โ‚ฌ196.13 B22.4%
2021โ‚ฌ160.23 B50.46%
2020โ‚ฌ106.49 B-8.84%
2019โ‚ฌ116.82 B41.54%
2018โ‚ฌ82.53 B13.67%
2017โ‚ฌ72.61 B10.75%
2016โ‚ฌ65.56 B-17.08%
2015โ‚ฌ79.07 B7.38%
2014โ‚ฌ73.64 B37.24%
2013โ‚ฌ53.65 B21.08%
2012โ‚ฌ44.31 B-3.8%
2011โ‚ฌ46.06 B-5.85%
2010โ‚ฌ48.92 B2.93%
2009โ‚ฌ47.53 B11.9%
2008โ‚ฌ42.48 B-0.58%
2007โ‚ฌ42.72 B-31.27%
2006โ‚ฌ62.17 B-5.64%
2005โ‚ฌ65.88 B49.4%
2004โ‚ฌ44.10 B-32.21%
2003โ‚ฌ65.05 B12.77%
2002โ‚ฌ57.69 B-37.35%
2001โ‚ฌ92.09 B-4.61%
2000โ‚ฌ96.54 B31.02%
1999โ‚ฌ73.68 B105.13%
1998โ‚ฌ35.92 B24.76%
1997โ‚ฌ28.79 B28.82%
1996โ‚ฌ22.35 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of AstraZeneca was reported to be:

โ‚ฌ257.47 Billion
by Nasdaq info icon info icon
โ‚ฌ257.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Bristol-Myers Squibb
BMY
โ‚ฌ97.81 B-61.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ124.32 B-50.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ233.57 B-6.96%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ86.68 B-65.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚ฌ98.70 B-60.68%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
โ‚ฌ785.39 B 212.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ449.22 B 78.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ185.41 B-26.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ21.21 B-91.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ235.99 B-5.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland